home / stock / ruby / ruby news


RUBY News and Press, Rubius Therapeutics Inc. From 04/12/21

Stock Information

Company Name: Rubius Therapeutics Inc.
Stock Symbol: RUBY
Market: OTC
Website: rubiustx.com

Menu

RUBY RUBY Quote RUBY Short RUBY News RUBY Articles RUBY Message Board
Get RUBY Alerts

News, Short Squeeze, Breakout and More Instantly...

RUBY - Rubius Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of RTX-321 for the Treatment of HPV 16-Positive Cancers

CAMBRIDGE, Mass., April 12, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announce...

RUBY - Rubius Therapeutics to present early-stage RTX-240 study results at AACR

Rubius Therapeutics (RUBY) announces that initial clinical results from its ongoing Phase 1/2 study of RTX-240 in advanced solid tumors will be presented at the American Association for Cancer Research ((AACR)) Virtual Annual Meeting.Posters will be available online tomorrow on the AACR websi...

RUBY - Rubius Therapeutics Presents Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting

CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today reprised...

RUBY - Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer

Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer PR Newswire CAMBRIDGE, Mass. , March 30, 2021 /PRNewswire/ -- Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the pot...

RUBY - 4 Top Health Care Stocks To Watch This Week

Should Investors Be Watching These Top Health Care Stocks Right Now? Most would know that health care stocks are amongst the top performers throughout the current pandemic. Some might even say that the sector is among the best to invest in now. For one thing, the industry is hom...

RUBY - Best Stocks To Buy In April 2021? 4 Biotech Stocks To Watch This Week

Do You Have These Trending Biotech Stocks On Your Watchlist This Week? Biotech companies play a major role in advancing longevity and medicine, even more so as we recover from the coronavirus pandemic. It is this importance that made biotech stocks a major hit among investors, a...

RUBY - XOMA, VUZI, MX and DISCA among midday movers

Gainers: Wah Fu Education (WAFU) +214%.China Liberal Education (CLEU) +37%.Helius Medical Technologies (HSDT) +34%.Four Seasons Education (FEDU) +31%.MagnaChip Semiconductor (MX) +27%.FreightCar America (RAIL) +25%.NextDecade (NEXT) +25%.180 Life Sciences (ATNF) +25%.XOMA (XOMA...

RUBY - LPCN, SGLB, NRG and CHFS among midday movers

Gainers: Takung Art (TKAT) +122%.Zhongchao (ZCMD) +52%.Oriental Culture (OCG) +43%.Integrated Media Technology (IMTE) +43%.Immatics (IMTX) +33%.Puyi (PUYI) +29%.Willis Lease Finance (WLFC) +24%.Lipocine (LPCN) +24%.Liquid Media (YVR) +21%.Sigma Labs (SGLB) +20%.Losers: Sun...

RUBY - Zhongchao, Immatics leads healthcare gainers; SunLink Health Systems, Rubius Therapeutics among major losers

Gainers: Zhongchao (ZCMD) +53%, Immatics (IMTX) +42%, Lipocine (LPCN) +23%, FSD Pharma (HUGE) +18%, Nabriva Therapeutics (NBRV) +18%.Losers: SunLink Health Systems (SSY) -28%, Rubius Therapeutics (RUBY) -17%, CHF Solutions CHFS&...

RUBY - Rubius Therapeutics prices upsized $200M public offering

Rubius Therapeutics (RUBY) has upsized and priced a previously announced public offering of shares at $29/share.Proceeds from the offering of 6,896,552 shares are now expected to be $200M.The offering is expected to close on March 19.Rubius shares were up 1.4% to $32.45 in...

Previous 10 Next 10